BioDiscovery Releases Nexus Expression version 2 for Gene Regulation Analysis

Share Article

BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of Nexus Expression version 2 for gene expression analysis. Nexus Expression provides users an intuitive yet powerful interface for using gene expression results to associate sample attributes with gene annotations and biological processes. New features in version 2 make it even easier for users to load data with a one-click tool and to find relevant biological information.

BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of Nexus Expression version 2 for gene expression analysis. Nexus Expression provides users an intuitive yet powerful interface for using gene expression results to associate sample attributes with gene annotations and biological processes. New features in version 2 make it even easier for users to load data with a one-click tool and to find relevant biological information. Users can identify genes with expression profiles matching that of a desired gene, in a single click. An extensive new library of pathways and gene sets are now provided to identify, in a single step, the important biological implications of differential gene regulation. In addition, new features facilitate data loading from array manufacturer’s software with a new plug-in for Illumina’s software as well as support for CEL files and annotation files from Affymetrix arrays.

“Nexus Expression is the second product in our Nexus family of modular software applications for genomic studies. New features in version 2 further expand on tools to make it easy for scientists to obtain relevant results in minimal time. Flexibility, speed, and ease of use is an important design element in the Nexus family of products and now with additional licensing options that allow users to create a customized package with Nexus modules, integrated genomics analysis is more efficient and cost effective.” said Dr. Soheil Shams, President of BioDiscovery, Inc.

Nexus Expression is a platform independent product and supports all array platforms including Affymetrix, Agilent, Illumina, Roche NimbleGen, and custom arrays. With single mouse clicks, the user can cluster genes and samples to discover expression patterns, simultaneously compare expression profiles of multiple comparisons alongside gene annotations, display significant genes in affected biological processes, perform enrichment analysis to identify genes that are significantly overrepresented in a population, and much more. With an intuitive interface and rich graphical and numerical outputs that are publication ready, Nexus Expression is an ideal product for those performing gene or miRNA expression analysis.

About BioDiscovery, Inc.
BioDiscovery is a leader in the development of microarray advanced bioinformatics software and services that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology. Contact BioDiscovery: 310-414-8100 or http://www.biodiscovery.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Soheil Shams
Visit website